Skip to main content
Top

Breast Cancer

Issue 1/2020

Content (18 Articles)

Open Access Breast Cancer Special Article

The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient

Hiroji Iwata, Shigehira Saji, Masahiko Ikeda, Masashi Inokuchi, Takayoshi Uematsu, Tatsuya Toyama, Rie Horii, Chikako Yamauchi

Open Access Breast Surgery Special Article

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition

Masafumi Inokuchi, Goro Kutomi, Yuko Kijima, Takehiko Sakai, Masataka Sawaki, Tadahiko Shien, Noriko Hanamura, Kenji Yano, Noriaki Wada, Shigehira Saji, Hiroji Iwata

Open Access Breast Cancer Special Article

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

Chikako Yamauchi, Michio Yoshimura, Kenji Sekiguchi, Yasushi Hamamoto, Naomi Nakajima, Naoko Sanuki, Etsuyo Ogo, Masahiko Oguchi, Shigehira Saji, Hiroji Iwata

Open Access Breast Cancer Special Article

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition

Takayoshi Uematsu, Kazutaka Nakashima, Mari Kikuchi, Kazunori Kubota, Akihiko Suzuki, Shogo Nakano, Kouichi Hirokaga, Ken Yamaguchi, Shigehira Saji, Hiroji Iwata

Mood Disorders Original Article

Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan

Yukiko Iioka, Takako Iwata, Hideko Yamauchi

Mastectomy Original Article

Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers

Naomi Nagura, Naoki Hayashi, Junko Takei, Atsushi Yoshida, Tomohiro Ochi, Yoshiko Iwahira, Hideko Yamauchi

Breast Cancer Original Article

Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema

Ayako Nakagawa, Hiroshi Fujimoto, Takeshi Nagashima, Takafumi Sangai, Mamoru Takada, Takahito Masuda, Ryotaro Teranaka, Satoshi Ota, Jun Matsushima, Shinsuke Akita, Masayuki Ohtsuka

Metastasis Original Article

Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004–2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society

Takashi Hojo, Norikazu Masuda, Takayuki Iwamoto, Naoki Niikura, Keisei Anan, Kenjiro Aogi, Tatsuya Ohnishi, Chisako Yamauchi, Masayuki Yoshida, Takayuki Kinoshita, Hideji Masuoka, Yasuaki Sagara, Takashi Sakatani, Yasuyuki Kojima, Hitoshi Tsuda, Hiraku Kumamaru, Hiroaki Miyata, Seigo Nakamura

Open Access Breast Cancer Original Article

High expression of soluble CD155 in estrogen receptor-negative breast cancer

Akiko Iguchi-Manaka, Genki Okumura, Emika Ichioka, Hiroko Kiyomatsu, Tatsuhiko Ikeda, Hiroko Bando, Akira Shibuya, Kazuko Shibuya

Open Access Nausea Original Article

Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study

Yoichi Naito, Yuichiro Kai, Takashi Ishikawa, Tomoyuki Fujita, Kanou Uehara, Hiroyoshi Doihara, Shinya Tokunaga, Mototsugu Shimokawa, Yoshinori Ito, Toshiaki Saeki

Open Access Magnetic Resonance Imaging Original Article

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities

Ayumi Izumori, Yumi Kokubu, Kazuko Sato, Naoya Gomi, Hidetomo Morizono, Takehiko Sakai, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno

Breast Cancer Original Article

Physical symptoms and components of labor tasks associated with upper limb disability among working breast cancer survivors

Natália de Souza Cunha, Kamilla Zomkowski, Bráulio Leal Fernandes, Cinara Sacomori, Adriana Coutinho de Azevedo Guimarães, Fabiana Flores Sperandio

Breast Cancer Original Article

miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2

Qiu-Yan Lin, Jia-Qi Wang, Li-Li Wu, Wei-E Zheng, Pei-Rui Chen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine